BP230- and BP180-specific auto-antibodies in bullous pemphigoid

Journal of Investigative Dermatology

Volumn 122, Issue 6, 2004, Pages 1413-1422

  Thoma Uszynski, Sybille ^a   Uter, Wolfgang ^a   Schwietzke, Susanne ^a   Hofmann, Silke C ^a   Hunziker, Thomas ^b   Bernard, Philippe ^c   Treudler, Regina ^d   Zouboulis, Christos C ^d   Schuler, Gerold ^a   Borradori, Luca ^e   Hertl, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Klinik und Poliklinik fur Dermatologie   (Switzerland)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adhesion molecules; Auto immunity; BP180; BP230 auto antibodies; Bullous pemphiqoid; Hemidesmosome

Indexed keywords

AUTOANTIBODY; BP180 AUTOANTIBODY; BP230 AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC CODE; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 2942532602     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22603.x     Document Type: Article

References (43)

1. Amagai M, Hashimoto T, Shimizu N, et al: Absorption of pathogenic auto-antibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 94:59-67, 1994
2. Balding SD, Prost C, Diaz LA, et al: Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106:141-146, 1996
3. Bedane C, McMillan JR, Balding SD, et al: Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida. J Invest Dermatol 108:901-907, 1997
4. Bernard P, Aucouturier P, Denis F, et al: Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol 54:484-494, 1990
5. Borradori L, Koch PJ, Niessen CM, et al: The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J Cell Biol 136:1333-1347, 1997
6. Borradori L, Sonnenberg A: Structure and function of hemidesmosomes: More than simple adhesion complexes. J Invest Dermatol 112:411-418, 1999
7. Dopp R, Schmidt E, Chimanovitch I, et al: IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: Serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42:577-583, 2000
8. Giudice GJ, Emery DJ, Diaz LA: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243-250, 1992
9. Giudice GJ, Emery DJ, Zelickson BD, et al: Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 151:5742-5750, 1993
10. Giudice GJ, Wilske KC, Anhalt GJ, et al: Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 102:878-881, 1994
11. Guo L, Degenstein L, Dowling J, et al: Gene targeting of BPAG1: Abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81:233-243, 1995
12. Haase C, Budinger L, Borradori L, et al: Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus- encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 110:282-286, 1998
13. Hall RP III, Murray JC, McCord MM, et al: Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: A potential animal model for bullous pemphigoid. J Invest Dermatol 101:9-14, 1993
14. Hata Y, Fujii Y, Tsunoda K, et al: Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression. J Dermatol Sci 23:183-190, 2000
15. Hofmann S, Thoma-Uszynski S, Hunziker T, et al: Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 119:1065-1073, 2002
16. Hopkinson SB, Riddelle KS, Jones JC: Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: Molecular and cell biologic characterization. J Invest Dermatol 99:264-270, 1992
17. Husz S, Kiss M, Janossy T, et al: Experimental mouse model of bullous pemphigoid using antibodies generated against an antigenic epitope of hemidesmosomal plaque protein BP230. J Invest Dermatol 119:724, 2002 (abstract)
18. Ishiko A, Shimizu H, Kikuchi A, et al: Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 91:1608-1615, 1993
19. Jordon RE, Beutner EH, Witebsky E, et al: Basement zone antibodies in bullous pemphigoid. JAMA 200:751-756, 1967
20. Koster J, Geerts D, Favre B, et al: Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J Cell Sci 116:387-399, 2003
21. Labib RS, Anhalt GJ, Patel HP, et al: Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231-1235, 1986
22. Laffitte E, Skaria M, Jaunin F, et al: Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol 144:760-768, 2001
23. Lever WF: Pemphigus. Medicine 32:1-123, 1953
24. Lin MS, Fu CL, Giudice GJ, et al: Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 115:955-961, 2000
25. Liu Z, Diaz LA, Troy JL, et al: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-2488, 1993
26. Matsumura K, Amagai M, Nishikawa T, et al: The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 288:507-509, 1996
27. McGrath JA, Gatalica B, Christiane AM, et al: Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 11:83-86, 1995
28. Murakami H, Nishioka S, Setterfield J, et al: Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 17:39-44, 1998
29. Nakatani C, Muramatsu T, Shirai T: Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): Immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 139:365-370, 1998
30. Nie Z, Hashimoto T: IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180. J Invest Dermatol 112:254-255, 1999
31. Nievers MG, Kuikman I, Geerts D, et al: Formation of hemidesmosome-like structures in the absence of ligand binding by the (alpha)6(beta)4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the (beta)4 integrin subunit. J Cell Sci 113 (Pt 6):963-973, 2000
32. Nishiyama T, Amano S, Tsunenaga M, et al: The importance of laminin 5 in the dermal-epidermal basement membrane. J Dermatol Sci 24 (Suppl. 1):S51-S59, 2000
33. Pulkkinen L, Uitto J: Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes. Exp Dermatol 7:46-64, 1998
34. Ruhrberg C, Watt FM: The plakin family: Versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev 7:392-397, 1997
35. Savage PA, Boniface JJ, Davis MM: A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485-492, 1999
36. Schmidt E, Obe K, Brocker EB, et al: Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136:174-178, 2000
37. Seishima M, Izumi T, Kanoh H, et al: Demonstration of antibody to 230 kDa bullous pemphigoid antigen in lichen planus-like keratosis. Eur J Dermatol 9:393-396, 1999a
38. Seishima M, Izumi T, Kitajima Y: Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid. Eur J Dermatol 9:39-42, 1999b
39. Skaria M, Jaunin F, Hunziker T, et al: IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 114:998-1004, 2000
40. Stanley JR, Tanaka T, Mueller S, et al: Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 82:1864-1870, 1988
41. Witte S: Macro for generation of ROC-curves. Proceedings of the Sixth Conference of SAS Application in Research and Development, Dortmund, 2002
42. Zillikens D, Mascaro JM, Rose PA, et al: A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 109:679-683, 1997a
43. Zillikens D, Rose PA, Balding SD, et al: Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 109:573-579, 1997b